This session introduces the concept of Life Cycle Assessments and their importance for the Pharmaceutical industry and supply chain. An LCA Framework facilitate can a universal approach to assessing the environmental impact of pharmaceutical products. This should enable pharmaceutical companies and their stakeholders, including payers, to make informed choices about product development and patient care.

During the session, you will hear PSCI’s plan to support suppliers of the Pharmaceutical industry respond to expectations to deliver product-level information. You will also hear about the work from the Pharmaceutical LCA Consortium and how they are collaborating with the PSCI.

Speakers
Andrej Szijjarto, Sustainable Product Design Lead, Novartis
Bridget Ferrari, Director, Supplier Sustainability, Takeda